Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2023-01-19 00:00:00 ET · period of report 2023-01-17 · accession 0001209191-23-004127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-19 | 2023-01-17+ | RLAY | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $5.04 | +84.0K | 282.6K | +42% | +$423.4K |
| DM | 2023-01-19 | 2023-01-17+ | RLAY | Patel Sanjiv | Pres, CEO, Dir | S - Sale+OE | $20.37 | -84.0K | 254.6K | -25% | -$1.71M |
| DM | 2023-01-19 | 2023-01-17 | RLAY | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $0.00 | +1.40M | 701.7K | New | $0 |
| DM | 2023-01-19 | 2023-01-17+ | RLAY | Patel Sanjiv | Pres, CEO, Dir | M - OptEx | $0.00 | -84.0K | 610.8K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-18 | M | A | 28,000 | $5.04 | 282,554 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-18 | S | D | 28,000 | $20.87 | 254,554 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $20.35 to $21.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2023-01-17 | S | D | 28,000 | $20.23 | 254,554 | D | — | — | |
| 4 | Common | Common Stock | 2023-01-17 | M | A | 28,000 | $5.04 | 282,554 | D | — | — | |
| 5 | Common | Common Stock | 2023-01-19 | M | A | 28,000 | $5.04 | 282,554 | D | — | — | |
| 6 | Common | Common Stock | 2023-01-19 | S | D | 28,000 | $20.02 | 254,554 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $20 to $20.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-01-17 | A | A | 701,680 | $0.00 | 701,680 | D | $20.45 · — to 2033-01-16 | 701,680 Common Stock | (F6) The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 17, 2023, subject to the reporting person's continued service with the Issuer through each vesting date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-01-17 | A | A | 701,680 | $0.00 | 701,680 | D | $20.45 · — to 2033-01-16 | 701,680 Common Stock | (F7) Such option was granted pursuant to the terms of the Issuer's 2020 Stock Option and Incentive Plan and becomes exercisable, if at all, in twelve equal quarterly installments if the last quoted trading price per share of the Issuer's common stock on the Nasdaq Global Market during any fifteen consecutive calendar day period is at least $35.00; provided that the reporting person maintains a service relationship with the Issuer. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-01-17 | M | D | 28,000 | $0.00 | 666,779 | D | $5.04 · — to 2029-04-22 | 28,000 Common Stock | (F5) The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2023-01-18 | M | D | 28,000 | $0.00 | 638,779 | D | $5.04 · — to 2029-04-22 | 28,000 Common Stock | (F5) The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date. |
| 11 | Derivative | Stock Option (Right to Buy) | 2023-01-19 | M | D | 28,000 | $0.00 | 610,779 | D | $5.04 · — to 2029-04-22 | 28,000 Common Stock | (F5) The shares underlying this option shall vest in sixteen (16) equal quarterly installments after April 23, 2019, subject to the reporting person's continued employment through each applicable vesting date. |